Ogata M - Search Results

1

Reduction and Escalation in the Dose of Sunitinib Were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine.

Ogata M, Satake H, Ogata T, Hatachi Y, Hara S, Hirota S, Yasui H. Ogata M, et al. Among authors: ogata t. Intern Med. 2019 Nov 15;58(22):3243-3246. doi: 10.2169/internalmedicine.2806-19. Epub 2019 Jul 22. Intern Med. 2019. PMID: 31327822 Free PMC article.

2

Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation.

Ogata M, Hatachi Y, Ogata T, Satake H, Imai Y, Yasui H. Ogata M, et al. Among authors: ogata t. Intern Med. 2019 Apr 1;58(7):1029-1032. doi: 10.2169/internalmedicine.1640-18. Epub 2018 Nov 19. Intern Med. 2019. PMID: 30449794 Free PMC article.

3

Oxaliplatin-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Pancreatic Cancer: A Case Report.

Ogata T, Satake H, Ogata M, Hatachi Y, Yasui H. Ogata T, et al. Among authors: ogata m. Case Rep Oncol. 2017 Oct 10;10(3):885-889. doi: 10.1159/000481398. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29118705 Free PMC article.

4

Hyperprogressive Disease in the Irradiation Field after a Single Dose of Nivolumab for Gastric Cancer: A Case Report.

Ogata T, Satake H, Ogata M, Hatachi Y, Yasui H. Ogata T, et al. Among authors: ogata m. Case Rep Oncol. 2018 Mar 7;11(1):143-150. doi: 10.1159/000487477. eCollection 2018 Jan-Apr. Case Rep Oncol. 2018. PMID: 29681813 Free PMC article.

5

Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study.

Ogata T, Satake H, Ogata M, Hatachi Y, Inoue K, Hamada M, Yasui H. Ogata T, et al. Among authors: ogata m. Oncotarget. 2018 Oct 2;9(77):34520-34527. doi: 10.18632/oncotarget.26145. eCollection 2018 Oct 2. Oncotarget. 2018. PMID: 30349646 Free PMC article.

6

Acute Liver Failure with Diffuse Liver Metastasis from Breast Cancer, Not Detected by Computed Tomography: 2 Case Reports.

Ogata T, Kikawa Y, Ogata M, Satake H, Hatachi Y, Yasui H. Ogata T, et al. Among authors: ogata m. Case Rep Oncol. 2018 Oct 31;11(3):699-704. doi: 10.1159/000493848. eCollection 2018 Sep-Dec. Case Rep Oncol. 2018. PMID: 30483101 Free PMC article.

7

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study.

Ogata T, Satake H, Ogata M, Hatachi Y, Maruoka H, Yamashita D, Hashida H, Hamada M, Yasui H. Ogata T, et al. Among authors: ogata m. Oncotarget. 2019 Feb 1;10(10):1070-1084. doi: 10.18632/oncotarget.26626. eCollection 2019 Feb 1. Oncotarget. 2019. PMID: 30800219 Free PMC article.

8

Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.

Ogata M, Kotaka M, Ogata T, Hatachi Y, Yasui H, Kato T, Tsuji A, Satake H. Ogata M, et al. Among authors: ogata t. PLoS One. 2020 Jun 12;15(6):e0234314. doi: 10.1371/journal.pone.0234314. eCollection 2020. PLoS One. 2020. PMID: 32530932 Free PMC article.

9

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Active Cancer.

Ogata M, Ama Y, Ogata T, Hirabatake M, Yasui H, Satake H. Ogata M, et al. Among authors: ogata t. In Vivo. 2021 Sep-Oct;35(5):2747-2753. doi: 10.21873/invivo.12559. In Vivo. 2021. PMID: 34410964 Free PMC article.

10

An electron microscopic study of Helicobacter pylori in the surface mucous gel layer.

Ogata M, Araki K, Ogata T. Ogata M, et al. Among authors: ogata t. Histol Histopathol. 1998 Apr;13(2):347-58. doi: 10.14670/HH-13.347. Histol Histopathol. 1998. PMID: 9589892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,502 results

Search Page

Filters